Follow
Harald Wajant
Harald Wajant
Professor, University Hospital of Würzburg
Verified email at mail.uni-wuerzburg.de
Title
Cited by
Cited by
Year
Tumor necrosis factor signaling
H Wajant, K Pfizenmaier, P Scheurich
Cell Death & Differentiation 10 (1), 45-65, 2003
32992003
The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor
M Grell, E Douni, H Wajant, M Löhden, M Clauss, B Maxeiner, ...
Cell 83 (5), 793-802, 1995
17521995
The Fas signaling pathway: more than a paradigm
H Wajant
Science 296 (5573), 1635-1636, 2002
14782002
NF-κB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling
S Kreuz, D Siegmund, P Scheurich, H Wajant
Molecular and cellular biology, 2001
7922001
The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor
M Grell, H Wajant, G Zimmermann, P Scheurich
Proceedings of the National Academy of Sciences 95 (2), 570-575, 1998
6331998
The CD95 receptor: apoptosis revisited
ME Peter, RC Budd, J Desbarats, SM Hedrick, AO Hueber, MK Newell, ...
Cell 129 (3), 447-450, 2007
4852007
The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators
H Wajant, F Henkler, P Scheurich
Cellular signalling 13 (6), 389-400, 2001
4632001
Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF‐R1 activation by endogenous membrane‐anchored TNF
M Grell, G Zimmermann, E Gottfried, CM Chen, U Grünwald, DCS Huang, ...
The EMBO journal, 1999
3821999
Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8
M Fotin-Mleczek, F Henkler, D Samel, M Reichwein, A Hausser, I Parmryd, ...
Journal of cell science 115 (13), 2757-2770, 2002
3542002
TNFR1 and TNFR2 in the control of the life and death balance of macrophages
H Wajant, D Siegmund
Frontiers in cell and developmental biology 7, 91, 2019
3512019
TNFR1‐induced activation of the classical NF‐κB pathway
H Wajant, P Scheurich
The FEBS journal 278 (6), 862-876, 2011
3492011
Anti–tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis
JH Egberts, V Cloosters, A Noack, B Schniewind, L Thon, S Klose, ...
Cancer research 68 (5), 1443-1450, 2008
3422008
NFκB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP
S Kreuz, D Siegmund, JJ Rumpf, D Samel, M Leverkus, O Janssen, ...
The Journal of cell biology 166 (3), 369-380, 2004
3092004
Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis
IH Engels, A Stepczynska, C Stroh, K Lauber, C Berg, R Schwenzer, ...
Oncogene 19 (40), 4563-4573, 2000
3092000
Differential activation of TRAIL-R1 and-2 by soluble and membrane TRAIL allows selective surface antigen-directed activation of TRAIL-R2 by a soluble TRAIL derivative
H Wajant, D Moosmayer, T Wüest, T Bartke, E Gerlach, U Schönherr, ...
Oncogene 20 (30), 4101-4106, 2001
2842001
Non-apoptotic Fas signaling
H Wajant, K Pfizenmaier, P Scheurich
Cytokine & growth factor reviews 14 (1), 53-66, 2003
2792003
TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma
A Trauzold, D Siegmund, B Schniewind, B Sipos, J Egberts, D Zorenkov, ...
Oncogene 25 (56), 7434-7439, 2006
2702006
Death receptors
H Wajant
Essays in biochemistry 39, 53-71, 2003
2552003
Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80: requirement of the TNF receptor-associated factor-2 binding site.
T Weiss, M Grell, B Hessabi, S Bourteele, G Mueller, P Scheurich, ...
Journal of immunology (Baltimore, Md.: 1950) 158 (5), 2398-2404, 1997
2401997
Tumor necrosis factor receptor-associated factor (TRAF) 2 and its role in TNF signaling
H Wajant, P Scheurich
The international journal of biochemistry & cell biology 33 (1), 19-32, 2001
2292001
The system can't perform the operation now. Try again later.
Articles 1–20